Lecture Notes - THC and Physical Dependence

Lecture 12: THC and Physical Dependence

Overview

  • The lecture continues the discussion on THC (Tetrahydrocannabinol), focusing on two main questions:

    • Does tolerance develop to the effects of THC?

    • Is physical dependence indicated by withdrawal syndrome associated with THC?

Tolerance to THC

  • Studies (both animal and human) indicate that tolerance develops to almost all effects of THC.

  • In humans, tolerance can be observed in self-reported intoxication levels (the "high" effect), often leading individuals to increase their dosages to regain the original effects.

  • Important points about tolerance:

    • Requires high blood THC levels and extended periods of use.

    • Recreational users who utilize THC infrequently are less likely to develop tolerance or physical dependence.

  • Implications due to increased marijuana legalization:

    • Higher THC levels in current marijuana strains may lead to increased tolerance and potential physical dependence in users.

Gender Differences in THC Effects

  • Research indicates that females experience different effects with THC compared to males:

    • Greater initial sensitivity to THC.

    • Greater development of tolerance.

    • More severe withdrawal symptoms indicative of physical dependence.

  • This observation parallels previous discussions on the gender differences in the effects of alcohol.

Physical Dependence and Withdrawal Symptoms

  • Previous beliefs: THC was thought not to produce physical dependence. Current understanding is that:

    • THC does induce physical dependence, evidenced by withdrawal symptoms.

    • Withdrawal symptoms include:

      • Mental and physical discomfort upon cessation.

  • Reasons for previous skepticism regarding THC and dependence:

    • High dosing required for tolerance, affecting probability of developing physical dependence in typical recreational users.

    • THC's long elimination half-life (up to 5 days) contributes to less severe withdrawal symptoms. Those undergoing withdrawal are essentially weaning off gradually rather than stopping abruptly.

    • Lack of a THC antagonist historically made it challenging to assess withdrawal effects accurately. However, a THC antagonist, Rimonabant, now allows for effective testing of physical dependence in research.

Withdrawal Symptoms in Research

  • Research findings:

    • Animals (e.g., rats) show withdrawal symptoms resembling those of wet dog shakes and retropulsion.

    • Monkeys display tremors, aggression, and irritability during withdrawal.

    • Human studies show similarities in withdrawal symptoms between cannabis and tobacco, confirming the physical dependence of cannabis.

      • Symptoms associated with tobacco withdrawal that are mirrored in cannabis withdrawal: irritability, insomnia, etc.

      • Notable exception: Cannabis users tend to experience appetite suppression while tobacco users typically experience an appetite increase during withdrawal.

Duration and Nature of Withdrawal Symptoms

  • Acute withdrawal symptoms generally subside within 7 to 10 days.

  • Prolonged effects, termed post-acute withdrawal symptoms (PAWS), can persist for weeks, months, or even years, potentially leading to cravings and relapse.

Treatment of Marijuana Use Disorder (MUD)

  • Approximately 30% of marijuana users may meet the criteria for MUD at some point in their lives.

  • Factors influencing the likelihood of developing MUD:

    • Age of onset: Early use (before age 18) significantly increases the risk (7-fold increase).

      • Majority of users typically begin before age 18, raising concerns for future dependence.

  • Treatment-seeking Statistics:

    • Around 15% of individuals seeking treatment for use disorders report marijuana as their primary substance of concern.

    • Profile of treatment seekers: predominantly young males, often Caucasian.

Comparison of Addiction Potential with Other Substances

  • Probability of requiring treatment following recreational use:

    • Marijuana: ~10%

    • Alcohol: 15-25%

    • Cocaine: ~17%

    • Heroin: ~23%

    • Tobacco: Highest likelihood

Treatment Approaches for MUD

  • Treatment modalities for MUD are similar to those used for other substance use disorders (e.g., alcohol, cocaine).

  • No specific pharmacological treatment currently exists for MUD, unlike treatments available for alcohol use disorder (e.g., Naltrexone, Acamprosate) or for opioid use disorder (e.g., Methadone, Buprenorphine).

  • Treatment outcomes suggest similar effectiveness across different substances, implying common underlying causes for substance use disorders regardless of the specific drug used.

Synthetic Cannabinoids

  • Naturally occurring THC-like substance: Anandamide.

  • Development of synthetic cannabinoids aimed to enhance effectiveness or minimize side effects.

  • First synthetic cannabinoid developed by John Huffman (no need to remember the name).

  • Key Characteristics of Synthetic Cannabinoids:

    • Known as new psychoactive substances, often referred to as "Spice."

    • Produced in illegal labs leading to unpredictable and potent THC-like effects, including severe adverse reactions (e.g., seizures).

    • Estimated 30,000 emergency room visits annually linked to synthetic cannabinoid use.

  • Comparison of THC potency:

    • Naturally occurring THC's dose for specific effects vs. synthetic cannabinoids requiring significantly lower doses to achieve similar effects, showing their increased potency.

Conclusion

  • The discussion wraps up the effects and implications surrounding THC and leads into the next lecture covering tobacco use.